The same genetic variants that have been uncovered in patients with two other types of cardiomyopathy are also present in an uncommonly high proportion of people with cancer therapy-induced cardiomyopathy (CCM), researchers reported in Circulation.
The FDA has cleared Gelesis100 hydrogel capsules to be used as a weight management aid alongside diet and exercise in adults with body mass indexes (BMIs) ranging from 25 to 40, according to an April 14 press release from the product’s manufacturer.
DUBLIN and LONDON — April 17, 2019 — Medtronic plc (NYSE:MDT) today announced five-year outcomes from the VeClose Extension Study. Nick Morrison, M.D., Center for Vein Restoration, Mesa, Ariz., presented at the 2019 Charing Cross Symposium in London.
Several professional medical societies have now weighed in on a bill introduced to Congress on April 9 which seeks to prevent physicians from self-referring Medicare patients to in-office “ancillary services” including advanced imaging, anatomic pathology, radiation therapy and physical therapy.
The FDA’s decision to mandate labeling of added sugar content on packaged foods and beverages is estimated to prevent nearly 1 million cases of diabetes and cardiovascular disease over the next 20 years and save the U.S. $31 billion in net healthcare costs over that timeframe.
More than 80% of stable patients with ST-segment elevation myocardial infarction (STEMI) are treated in the intensive care unit despite only 16% of them experiencing complications that require an ICU stay, according to a U.S. registry analysis published in JACC: Cardiovascular Interventions.
The Heart Rhythm Society's 2019 scientific sessions will be held May 8-11 in San Francisco, a venue that enabled the program committee to tap into Silicon Valley’s expertise with digital health, emerging technology and innovation. HRS.19 Program Director Christine Albert, MD, MPH, gave Cardiovascular Business a preview of meeting highlights.
Researchers at Tel Aviv University in Israel have 3D-printed what they said is the first vascularized heart using a patient’s own cells and biological materials.
The U.S. Department of Energy (DOE) has transferred 206 acres of land in Oak Ridge, Tennessee, to Coqui Radio Pharmaceuticals so the company can build a facility that domestically produces Molybdenum-99 (Mo-99), the most widely used isotope for nuclear imaging procedures.
Quantifying a patient’s blood-brain barrier dysfunction (BBBD) could help inform risk stratification and stroke prevention strategies following a transient ischemic attack (TIA), researchers reported in the May edition of Stroke.
